EUS引导下引流症状性术后积液:干预时机与临床结局的回顾性队列研究
单中心回顾性队列纳入2013至2023年85例症状性术后积液患者,比较急性(≤15天)、早期(16-30天)与延迟(>30天)EUS引导下引流。技术成功率和临床成功率分别为94%和79%,不同时机组间无显著差异,不良事件率相似。经胃途径与临床成功相关且不良事件更少,经十二指肠途径预示技术及临床失败。
要点
- 急性与早期EUS引导下引流在经选择的症状性术后积液中技术安全且临床有效。
- 引流时机(急性≤15天、早期16-30天、延迟>30天)不影响技术或临床成功率。
- 经胃途径与临床成功相关且不良事件更少,经十二指肠途径预示失败。
核心结论
- 在经仔细选择的症状性术后积液患者中,急性与早期EUS引导下置入腔壁贴合金属支架引流技术安全且临床有效,可能避免ERCP、经皮引流或手术等更高并发症的干预。
研究设计与样本
- 单中心回顾性队列研究,纳入2013至2023年因症状性术后积液接受EUS引导下引流的85例患者。
主要发现
- 85例中61%曾接受远端胰腺切除联合脾切除,59%在术后≤30天需引流,28%为急性干预。
- 83%使用腔壁贴合金属支架,中位内镜次数2次(IQR 2-3),总体技术成功率94%、临床成功率79%。
- 技术成功率按急性、早期、延迟分别为92%、96%、94%(P=0.86),临床成功率分别为83%、85%、71%(P=0.37)。
- 不良事件率各组相似(P=0.85);经胃途径与临床成功相关(P<0.001)且不良事件更少(P=0.03)。
关键数值与推荐
- 技术成功定义为首次内镜下经腔壁置入支架成功进入并引流术后积液。
- 临床成功定义为影像学或超声内镜确认症状性术后积液改善且无需进一步经皮或手术干预。
- 干预时机分组:急性≤15天,早期16-30天,延迟>30天。
临床怎么用
- 对经选择的症状性术后积液患者,可考虑在15天内或16-30天行EUS引导下引流,不必一律延迟至4周。
- 优先选择经胃途径以提高临床成功率并减少不良事件,经十二指肠途径需谨慎评估。
局限性
- 单中心回顾性设计,样本量85例,结果需进一步随机前瞻性研究验证。
- 技术及临床成功与不良事件的预测因素尚待前瞻性研究明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Symptomatic postoperative fluid collections (POFCs) can result in significant morbidity and mortality after abdominal surgery requiring timely intervention. EUS-guided drainage is traditionally delayed up to four weeks to allow wall maturation and reduce perforation or peritonitis risk. However, some POFCs may be suitable for earlier intervention. This study compared the efficacy and safety of acute (≤ 15 days), early (16-30 days), and delayed (> 30 days) EUS-guided drainage. METHODS: A retrospective cohort of patients undergoing EUS-guided drainage for symptomatic POFCs between 2013 and 2023 at a single tertiary center was evaluated. Technical success was defined as accessing and draining a POFC by transmural stent placement on initial endoscopy. Clinical success was defined as radiographically or endosonographically confirmed symptomatic POFC improvement without further percutaneous or surgical intervention. RESULTS: Among 85 patients with POFCs, most (61%) had undergone distal pancreatectomy with splenectomy. 59% required drainage ≤ 30 days after surgery, with 28% managed acutely. Most (83%) received lumen-apposing metal stents. Overall technical and clinical success rates were 94% and 79%, respectively, after a median 2 endoscopies (IQR 2-3). Success did not differ by timing (technical: 92% vs. 96% vs. 94%; clinical: 83% vs. 85% vs. 71%; P = 0.86 and P = 0.37). Adverse event rates were similar across groups (P = 0.85). Transgastric access was associated with clinical success (P < 0.001) and fewer adverse events (P = 0.03). Transduodenal access predicted technical (P = .05) and clinical failure (P = 0.02). CONCLUSIONS: In this large single-center experience of symptomatic POFCS, acute and early EUS-guided drainage with lumen-apposing metal stents in carefully selected patients was found to be technically safe and clinically effective, potentially avoiding more morbid interventions such as ERCP, percutaneous drainage, or surgery. Further randomized, prospective studies are needed to define predictors of technical and clinical success as well as adverse events.
引用
- Raza MH, Tiao JR, Wang CK, et al. EUS-guided drainage of symptomatic postoperative fluid collections: a retrospective cohort study evaluating timing of intervention and clinical outcomes. Surg Endosc. 2026. PMID: 42230364. doi:10.1007/s00464-026-12857-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。